Ertapenem is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Ertapenem Sodium.
| Product ID | 68001-408_0a1c58f3-7f03-4fb8-8389-17f5dab55e0b |
| NDC | 68001-408 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ertapenem |
| Generic Name | Ertapenem Sodium |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2019-08-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207647 |
| Labeler Name | BluePoint Laboratories |
| Substance Name | ERTAPENEM SODIUM |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Carbapenems [CS],Penem Antibacterial [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA207647 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-29 |
| Marketing Category | ANDA |
| Application Number | ANDA207647 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-29 |
| Ingredient | Strength |
|---|---|
| ERTAPENEM SODIUM | 1 g/20mL |
| SPL SET ID: | 8eccc96f-4b59-49ee-9997-365a24f59a24 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-3510 | Ertapenem | Ertapenem |
| 42023-221 | ERTAPENEM | ertapenem sodium |
| 44567-820 | ertapenem | ertapenem |
| 44647-051 | Ertapenem | Ertapenem Sodium |
| 55150-282 | Ertapenem | Ertapenem |
| 60505-6196 | Ertapenem | Ertapenem Sodium |
| 63323-823 | Ertapenem | Ertapenem |
| 68001-408 | Ertapenem | Ertapenem |
| 0143-9398 | ertapenem sodium | ertapenem sodium |
| 16714-889 | ERTAPENEM SODIUM | Ertapenem |
| 43598-901 | ERTAPENEM SODIUM | Ertapenem |
| 0006-3843 | INVANZ | ertapenem sodium |